Consistent evidence shows that in patients affected by thyroid cancer, the circulating levels of Acrp30 are deregulated compared to healthy controls, while the correlations between leptin and thyroid cancer are not clear. The gene discussed is ADIPOQ; the disease is thyroid gland carcinoma.